126 related articles for article (PubMed ID: 30567117)
1. Case of steroid-resistant Crohn's-associated bronchiolitis in the setting of quiescent gastrointestinal disease treated with infliximab.
Chuah CS; Noble C; Leitch A
BMJ Case Rep; 2018 Nov; 11(1):. PubMed ID: 30567117
[TBL] [Abstract][Full Text] [Related]
2. Granulomatous bronchiolitis of Crohn's disease successfully treated with inhaled budesonide.
Trow TK; Morris DG; Miller CR; Homer RJ
Thorax; 2009 Jun; 64(6):546-7. PubMed ID: 19478123
[TBL] [Abstract][Full Text] [Related]
3. An unusual cutaneous manifestation of Crohn's disease.
Weiser JA; Markowitz DM; Husain S; Grossman ME
Skinmed; 2011; 9(3):196-8. PubMed ID: 21675504
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and tolerability of repeated treatment with infliximab in patients with Crohn's disease: a retrospective data analysis in Germany.
Witthöft T; Ludwig D
Int J Colorectal Dis; 2005 Jan; 20(1):18-23. PubMed ID: 15459773
[TBL] [Abstract][Full Text] [Related]
5. Safe use of infliximab for the treatment of severe perianal Crohn's disease after diagnosis and treatment of lymphoma.
Bernardes C; Russo P; Carvalho D; Saiote J; Ramos J
Clin J Gastroenterol; 2018 Feb; 11(1):48-52. PubMed ID: 29168104
[TBL] [Abstract][Full Text] [Related]
6. De-escalation of Infliximab Maintenance Therapy from 8- to 10-week Dosing Interval Based on Faecal Calprotectin in Patients with Crohn's Disease.
Papamichael K; Karatzas P; Mantzaris GJ
J Crohns Colitis; 2016 Mar; 10(3):371-2. PubMed ID: 26546496
[No Abstract] [Full Text] [Related]
7. Metastatic Crohn's disease despite infliximab therapy.
Campos S; Coutinho I; Cardoso JC; Portela F
An Bras Dermatol; 2017; 92(5 Suppl 1):104-106. PubMed ID: 29267462
[TBL] [Abstract][Full Text] [Related]
8. Remission maintained by monotherapy after biological + immunosuppressive combination for Crohn's disease in clinical practice.
Ampuero J; Rojas-Feria M; Castro-Fernández M; Millán-Lorenzo M; Guerrero-Jiménez P; Romero-Gómez M
J Gastroenterol Hepatol; 2016 Jan; 31(1):112-8. PubMed ID: 26173493
[TBL] [Abstract][Full Text] [Related]
9. [Acute appendicitis in a patient with perianal Crohn's disease receiving infliximab].
Szakács Z; Faluhelyi N; Fincsur A; Papp A; Vincze Á; Bajor J
Orv Hetil; 2018 Mar; 159(10):405-409. PubMed ID: 29504422
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate for induction of remission in refractory Crohn's disease.
McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
[TBL] [Abstract][Full Text] [Related]
11. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
Borrelli O; Bascietto C; Viola F; Bueno de Mesquita M; Barbato M; Mancini V; Bosco S; Cucchiara S
Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204
[TBL] [Abstract][Full Text] [Related]
12. Severe Legionella pneumophila pneumonia following infliximab therapy in a patient with Crohn's disease.
Beigel F; Jürgens M; Filik L; Bader L; Lück C; Göke B; Ochsenkühn T; Brand S; Seiderer J
Inflamm Bowel Dis; 2009 Aug; 15(8):1240-4. PubMed ID: 19217020
[TBL] [Abstract][Full Text] [Related]
13. [Pneumocystis pneumonia during infliximab treatment for active Crohn's colitis].
Minnee RC; Stokkers P; Riemens SC; Hommes DW
Ned Tijdschr Geneeskd; 2005 Oct; 149(41):2290-5. PubMed ID: 16240855
[TBL] [Abstract][Full Text] [Related]
14. Infliximab in the treatment of Crohn's disease: a user's guide for clinicians.
Sandborn WJ; Hanauer SB
Am J Gastroenterol; 2002 Dec; 97(12):2962-72. PubMed ID: 12492177
[TBL] [Abstract][Full Text] [Related]
15. Case report of cheilitis granulomatosa and joint complaints as presentation of Crohn's disease.
Hoekman DR; Roelofs JJ; van Schuppen J; Schonenberg-Meinema D; D'Haens GR; Benninga MA
Clin J Gastroenterol; 2016 Apr; 9(2):73-8. PubMed ID: 27017505
[TBL] [Abstract][Full Text] [Related]
16. [Adalimumab treatment in infliximab-resistant pediatric patient with Crohn's disease].
Veres G; Putz R; Szabó D; Molnár K; Bodánszky H; Dezsofi A; Arató A
Orv Hetil; 2009 Oct; 150(40):1858-60. PubMed ID: 19789146
[TBL] [Abstract][Full Text] [Related]
17. Noninfectious interstitial lung disease during infliximab therapy: case report and literature review.
Caccaro R; Savarino E; D'Incà R; Sturniolo GC
World J Gastroenterol; 2013 Aug; 19(32):5377-80. PubMed ID: 23983443
[TBL] [Abstract][Full Text] [Related]
18. Prolonged duration of response to infliximab in early but not late pediatric Crohn's disease.
Kugathasan S; Werlin SL; Martinez A; Rivera MT; Heikenen JB; Binion DG
Am J Gastroenterol; 2000 Nov; 95(11):3189-94. PubMed ID: 11095340
[TBL] [Abstract][Full Text] [Related]
19. [Indications and results of infliximab in Crohn's disease].
Karoui S; Boubaker J; Filali A
Tunis Med; 2004 Dec; 82(12):1057-63. PubMed ID: 15822505
[TBL] [Abstract][Full Text] [Related]
20. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
